Skip to main content

JANE STREET GROUP, LLC

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$57,072
+$57,072 QoQ
Shares Held
14,634
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 86 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SABS Over Time

Shares Held

Position Value (USD)

Derivatives in SABS

reported options exposure · as of Jun 30, 2026
CallValue
$209,040
CallShares
53,600
PutValue
$883,350
PutShares
226,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,363,916,985 across 292 Biotechnology names. SABS ranks #234 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SABS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $883,350 226,500
2026-06-30 $209,040 53,600
2026-06-30 $57,072 14,634
2026-03-31 $276,143 72,100
2026-03-31 $39,449 10,300
2023-03-31 SABSW 10,628
2022-12-31 SABSW 10,888
2022-09-30 SABSW 10,488
2022-09-30 $16,791 23,954
2022-06-30 SABSW 10,572
2022-03-31 SABSW 11,322
2021-12-31 SABSW 13,550
2021-09-30 BCYP 35,717
2021-06-30 BCYP 36,029
2021-03-31 BCYP 18,552